This AMH expression pattern was similar to those previously described in CAIS patients by many groups [7,18].Finally, in order to specify the Leydig cell steroidogenic status, we also evaluated the 3β-hydroxysteroid dehydrogenase (3βHSD) expression by immunostaining (Figure 1, panels J-L). This evidence concerns the gene AMH and complete androgen insensitivity syndrome.